Merck KGaA (OTCMKTS:MKKGY) Earns Buy Rating from Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Merck KGaA (OTCMKTS:MKKGYFree Report) in a report issued on Thursday morning, Marketbeat.com reports. The firm issued a buy rating on the stock.

Merck KGaA Stock Up 1.3 %

Shares of MKKGY stock opened at $37.32 on Thursday. Merck KGaA has a 12-month low of $28.59 and a 12-month high of $39.17. The business’s fifty day simple moving average is $36.40 and its 200-day simple moving average is $35.01.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Recommended Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.